Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock?

Voyager Therapeutics (VYGR) shares ended the last trading session 11.6% higher at $5.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 18.1% gain over the past four weeks.The sudden surge in the stock price likely reflects the growing investor optimism regarding the potential of Voyager Therapeutics’ only clinical-pipeline candidate, VY7523 (anti-tau antibody), which is being developed in an early-stage study for ...